SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-361275
Filing Date
2021-12-17
Accepted
2021-12-17 16:59:38
Documents
16
Period of Report
2021-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d227281d8k.htm   iXBRL 8-K 28933
2 EX-1.1 d227281dex11.htm EX-1.1 217184
3 EX-5.1 d227281dex51.htm EX-5.1 8947
7 GRAPHIC g227281dsp03.jpg GRAPHIC 4111
8 GRAPHIC g227281dspw2.jpg GRAPHIC 13321
  Complete submission text file 0001193125-21-361275.txt   468429

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alxo-20211217.xsd EX-101.SCH 2902
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20211217_lab.xml EX-101.LAB 18124
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20211217_pre.xml EX-101.PRE 11412
9 EXTRACTED XBRL INSTANCE DOCUMENT d227281d8k_htm.xml XML 3413
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 211502361
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences